Whats new
Whats new.
CLSA - Efti & Keytruda’s excellent adventure; OS data shows meaningful benefit in NSCLC, without need for chemo (Analyst: Andrew Paine)
May 17th 2023
For a copy of this analyst report please contact your CLSA advisor
Whats new
May 17th 2023
For a copy of this analyst report please contact your CLSA advisor